Back to ALDX

Aldeyra Therapeutics, Inc. 8-K

Accession 0001193125-17-040567

Filing information

CIK
0001341235
Report date
2017-02-13
Filing date
2017-02-13
Form
8-K
Primary document
d335291d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.